Researchers report a clinical trial of a personalized vaccine that targets glioblastoma brain cancer has successfully improved survival rates for patients.
A new study has identified a number of cancer associated genes as being linked to ASD. Researchers suggest certain cancer treatments that target these genes may also be helpful in treating autism disorders.
Researchers have identified a number of environmental factors, including the herbicide Linuron, as inflammation activators in neurodegenerative disorders.
Researchers from UT Austin utilize deep learning and supercomputing to help identify brain tumors.
Researchers report they have developed a new method for treating cancer that has shown to almost completely eradicate the disease in cell cultures within the lab.
Researchers report on how exosomic miRNAs released within a tumor environment affect resistance to chemotherapy.
Researchers discover stem cells from a patient's own fat could potentially deliver new treatments directly to the brain after the removal of a glioblastoma, the most common form of brain cancer.
A newly developed ion pump can deliver cancer-fighting drugs more accurately, and with fewer side effects than conventional chemotherapy, to those with glioblastoma brain cancer.
Researchers report the addition of an FDA approved chemotherapy drug called hydroxyyurea to temozolomide helps to increase survival rates in animal models of glioblastoma.
A synthetic, non-toxic form of scorpion venom helps illuminate brain tumors when stimulated by a near-infrared laser. A clinical trial of the agent showed it to be safe for use in brain cancer patients.
Head and neck cancers involving HPV are on the rise and researchers fear we may be seeing the start of an epidemic.
A newly developed lab test can predict how quickly and aggressively glioblastoma brain cancer might lethally spread.
